Bio Essence (BIOE) Change in Receivables (2020 - 2026)
Bio Essence (BIOE) recorded quarterly Change in Receivables of -$18135.0 in Q1 2026, down 198.11% quarter-over-quarter from $18484.0 in Q4 2025, and down 691.29% on a YoY basis from $3067.0 in Q1 2025.
Bio Essence (BIOE) Change in Receivables (2020 - 2026) Analysis & Trends
Bio Essence's Change in Receivables history runs 7 years deep, the most recent figure standing at -$18135.0 for Q1 2026.
- In Q1 2026, Change in Receivables fell 691.29% year-over-year to -$18135.0; the TTM figure through Mar 2026 stood at -$2873.0 (up 98.48% YoY), while the FY2025 annual figure was $18329.0, up 257.71% from the prior year.
- Change in Receivables was -$18135.0 for Q1 2026 at Bio Essence, down from $18484.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $197295.0 in Q1 2024 to a low of -$131825.0 in Q3 2024.
- Historically, Change in Receivables has averaged $19.07 across 5 years, with a median of $30.0 in 2023.
- Biggest YoY gain for Change in Receivables was 3766.26% in 2024; the steepest drop was 5606.47% in 2024.
- A 5-year view of Change in Receivables shows it stood at -$31231.0 in 2022, then jumped by 64.13% to -$11202.0 in 2023, then tumbled by 438.71% to -$60346.0 in 2024, then surged by 130.63% to $18484.0 in 2025, then plunged by 198.11% to -$18135.0 in 2026.
- The last three Change in Receivables figures came in at -$18135.0 (Q1 2026), $18484.0 (Q4 2025), and -$3222.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -78.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 106.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -38.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 81.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 23.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 116.25 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.23 Mn |
| 10 | Bio Essence | - | - | 319,353.00 | -18,135.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18,135.00 |
| Mar 31, 2026 | -18,135.00 |
| Dec 31, 2025 | 18,484.00 |
| Dec 31, 2025 | 18,484.00 |
| Jun 30, 2025 | -3,222.00 |
| Jun 30, 2025 | -3,222.00 |
| Mar 31, 2025 | 3,067.00 |
| Mar 31, 2025 | 3,067.00 |
| Dec 31, 2024 | -60,346.00 |
| Dec 31, 2024 | -60,346.00 |
| Sep 30, 2024 | -131,825.00 |
| Sep 30, 2024 | -131,825.00 |
| Mar 31, 2024 | 197,295.00 |
| Mar 31, 2024 | 197,295.00 |
| Dec 31, 2023 | -11,202.00 |
| Dec 31, 2023 | -11,202.00 |
| Sep 30, 2023 | 2,394.00 |
| Sep 30, 2023 | 2,394.00 |
| Jun 30, 2023 | 30.00 |
| Jun 30, 2023 | 30.00 |